INDIA Biologics Market Economic Outlook and Regional Insights The INDIA Biologics Market Economic Outlook remains favorable with increasing investments in biotechnology, government incentives, and rising domestic demand. MRFR analysis suggests that India’s cost-effective manufacturing capabilities and skilled workforce make it an attractive hub for biologics production. Economic factors...

Fc fusion proteins represent a groundbreaking class of biopharmaceuticals that leverage the natural mechanism of the human antibody. By fusing a therapeutic protein, such as a cytokine, receptor, or enzyme, to the fragment crystallizable (Fc) region of an immunoglobulin G (IgG) antibody, scientists can dramatically extend the therapeutic agent's circulating half-life. This extension is...